Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer

Objectives: Stage III non-small cell lung cancer (NSCLC) has a poor prognosis. Reports suggest that five-year survival after current treatment is between 14 to 24 percent. The purpose of this retrospective study was to investigate the morbidity and mortality of patients diagnosed with stage III NSCL...

Full description

Bibliographic Details
Main Authors: Sibu P. Saha, Rohan J. Kalathiya, Daniel L. Davenport, Victor A. Ferraris, Timothy W. Mullett, Joseph B. Zwischenberger
Format: Article
Language:English
Published: Oman Medical Specialty Board 2014-01-01
Series:Oman Medical Journal
Subjects:
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=488&type=fultext